Modeling kidney injury caused by drugs
Establishment, Evaluation and Treatment Strategy of Drug-induced Kidney Injury Model
This study is trying to find a way to predict kidney problems in patients who have had kidney injury from medications to help understand how different drugs affect their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Sex | All |
| Sponsor | Zhejiang Provincial People's Hospital Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Trial ID | NCT06939387 on ClinicalTrials.gov |
What this trial studies
This observational study aims to establish a prediction model for renal dysfunction in patients who have experienced drug-induced acute kidney injury. It will analyze the prognosis associated with different drug treatments in these patients. By collecting and evaluating clinical data, the study seeks to identify patterns and outcomes related to kidney injury caused by medications.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who have experienced acute kidney injury due to drug exposure.
Not a fit: Patients on dialysis, those without baseline creatinine data, or those with obstructive acute kidney injury may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the understanding and management of drug-induced kidney injury, leading to better patient outcomes.
How similar studies have performed: While there have been studies on acute kidney injury, this specific observational approach to modeling drug-induced injury is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Drug-induce acute kidney injury Exclusion Criteria: * 1.Dialysis patients; 2.No baseline creatinine; 3.Obstructive AKI; 4.Clinical data were incomplete.
Where this trial is running
Hangzhou, Zhejiang
- Zhejiang Provincial People's Hospital — Hangzhou, Zhejiang, China (Recruiting)
Study contacts
- Study coordinator: xiaolan Ye, master
- Email: yexl1120@126.com
- Phone: +86-0571-85893117
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.